Resultados de la búsqueda 51-60 of 13744 for B cell lymphomas

  1. T-cell lymphoma - Médicos y departamentos - Mayo Clinic

    Mayo Clinic doctors and researchers are studying T-cell lymphomas to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is ...

  2. Linfoma cutáneo de linfocitos B - Descripción general - Mayo Clinic

    Blood Cancers & Disorders Discussions. roberthall0452 · Anyone else have Mantle Cell Lymphoma? 103 Replies Sun, Oct 26, 2025.

  3. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  4. Hematología - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  6. Linfoma de células del manto - Síntomas y causas - Mayo Clinic

    Mantle cell lymphoma: Epidemiology, pathobiology, clinical manifestations, diagnosis, and prognosis. ... B-cell lymphomas. National Comprehensive Cancer Network.

  7. Ensayos clínicos - Hematología

    ... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...

  8. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  9. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  10. Hematología - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...